Commercial Space Company Risk / Opportunity Ranking

Thesis: Reviewed evidence membership rationale suggests Skylo is positioned in standards-based direct-to-device satellite connectivity and had planned rollout across 37+ countries, but no kept post-recent evidence window direct positive evidence or representative articles were available for ranking, so the opportunity case is mostly ungrounded in these reviewed sources.

Why now: There is no fresh kept article evidence after the March 29, 2026 cutoff; timing support is weak and recency is effectively absent in the ranking payload.

Caveats: No evidence were kept after recent evidence window for ranking. Membership rationale is not sufficient by itself for a strong directional thesis.

Thesis: There may be some long-horizon opportunity from UK space-technology support and in-space manufacturing positioning, but these reviewed sources does not include kept citable evidence to substantiate a stronger thesis.

Why now: Why now is weak because the reviewed sources cites articles: and: in the membership rationale, but no or reviewed evidence are provided for ranking-grade citation.

Caveats: No article are provided for the referenced support articles. Cannot convert broad space-tech relevance into a strong opportunity thesis without direct evidence. Coverage after recent evidence window is empty.

Thesis: The reviewed sources rationale notes article context around the Space Force's Andromeda contract and selected operating companies, which could imply some opportunity if this candidate were clearly identified. However, the reviewed sources explicitly says the candidate name is not clearly tied in the summary to a specific qualifying company, and there are no available direct evidence after recent evidence window.

Why now: The only potential 'why now' is contract-related context in the membership rationale, but it is not sufficiently tied to this entity and no dated scoring evidence with is available.

Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Entity identification is unclear in the reviewed sources.

Thesis: The reviewed sources membership rationale says Spacety is a Chinese satellite startup focused on SAR satellites and had raised substantial funding ahead of an IPO, which could indicate commercial ambition if still current.

Why now: There is no dated evidence retained after recent evidence window for Spacety in these reviewed sources. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so recency is uncertain.

Caveats: No representative articles or evidence are provided after recent evidence window. The only support is the phase2 membership rationale, which is weaker than direct event/fact evidence and does not provide /article summaries here. Because there is no in-window evidence, scores remain low on both axes.

Thesis: Reviewed evidence context says SpinLaunch is developing a centrifugal satellite launcher, announced the Meridian Space broadband constellation, and selected Equinix for ground infrastructure, which could support a long-horizon platform build, but no within the recent evidence window direct evidence or cited article summaries are provided here.

Why now: Why-now is weak because the reviewed sources show 0 evidence kept after the 90-day recent evidence window, so recency cannot be established from local evidence.

Caveats: Phase2 membership rationale references and, but no article summaries or direct evidence are included, so they cannot be cited as factual support beyond noting the reviewed sources rationale. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Opportunity score kept low because positive thesis is not directly grounded in usable article evidence in these reviewed sources.

Thesis: Spire’s reviewed sources context supports that it designs, builds, and operates its own satellite constellation and provides data services, but no reviewed evidence survived the 90-day recent evidence window for directional ranking, so there is no strong 'why now' opportunity case in these reviewed sources.

Why now: There is no current catalyst in the kept ranking evidence. The only representative article provided is dated February 7, 2025, outside the recent evidence window, via at

Caveats: Zero evidence were kept after the 90-day recent evidence window. The available article context is outside recent evidence window and should not be treated as current catalyst evidence.

Thesis: The membership rationale says SSC Space provides tracking and communications for Artemis II and Firefly's Blue Ghost mission and is investing in RF and optical ground stations, which would suggest durable infrastructure relevance over a 1 year+ horizon if supported by available evidence. However, these reviewed sources provide no within the recent evidence window evidence or article for ranking use.

Why now: Why now is weak because no evidence survived into the ranking reviewed sources despite the membership rationale.

Caveats: Phase-2 membership rationale references: but no or direct evidence row is available here. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Do not infer opportunity from mission association alone without available evidence.

Thesis: The membership rationale says Telesat Lightspeed is a satellite broadband constellation with first satellites planned in December 2026, which could matter over 1 year+, but the reviewed sources provide no within the recent evidence window direct evidence or article summaries to support a stronger opportunity score.

Why now: No within the recent evidence window evidence were available for Telesat Corporation, so there is no current evidence-set-backed catalyst despite the membership rationale referencing future constellation timing.

Caveats: Membership rationale references article IDs and, but their contents are not included here for direct citation. Evidence recent evidence review shows 0 kept rows after the 90-day cutoff. As a result, scores are necessarily conservative.

Thesis: The ePlane Company has slight contextual upside because the membership rationale says it was listed among beneficiaries of India's spacetech/deeptech government RDI disbursal, which can be supportive for a 1 year+ strategic development thesis if confirmed with direct follow-through evidence (: unavailable in reviewed sources). However, no direct positive evidence are available in the reviewed sources.

Why now: The government RDI disbursal reference could matter on a 1 year+ horizon, but the reviewed sources lack timestamps, and direct evidence, limiting confidence in timing and materiality.

Caveats: No current evidence is provided for Government support mention is contextual and not enough alone to prove commercial traction. Zero evidence available after recent evidence window.

Thesis: True Anomaly has a slightly higher opportunity score than the no-evidence names because the membership rationale references a $650M raise, Jackal spacecraft work, and the Space Force Victus Haze mission, which would matter over a 1 year+ horizon if substantiated. However, no available within the recent evidence window evidence or article summaries are provided in these reviewed sources.

Why now: Why-now is weak because the cited raise and mission activity appear only in membership rationale, without scoreable dated article details in the current evidence set.

Caveats: Membership rationale cites, and, but the supporting articles are not available for direct use. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. A positive thesis requires positive evidence; membership rationale alone only supports a modest watchlist bias.

Thesis: Limited evidence-ranked opportunity: the reviewed sources membership rationale says Ulook plans RF ELINT/RF detection satellites by 2027 and appears in Indian space startup launch manifests, which implies product ambition and some ecosystem visibility, but no direct positive evidence or article summaries were available within the recent evidence window.

Why now: Why now is weak because the reviewed sources show two articles were considered for membership support, yet zero article context or evidence were available after recent evidence window; recency and milestone timing are therefore uncertain. The membership rationale references article IDs and, but no or article dates were provided in the reviewed sources.

Caveats: No direct positive or negative evidence were provided after recent evidence window. Membership rationale references article IDs and, but no are available, so those claims cannot be fully cited under the the evidence standard. Opportunity score is kept low because membership is not thesis attractiveness.

Thesis: The membership rationale confirms ULA remains in launch operations and competition context, but the reviewed sources provide no available within the recent evidence window direct event or fact evidence to support a stronger opportunity thesis.

Why now: The membership rationale cites articles: and: but no article summaries or evidence are available after recent evidence filtering for ranking.

Caveats: Launch-industry membership is not itself a directional thesis. Coverage debug shows zero evidence after recent evidence window despite many considered articles. No direct contract, launch cadence, backlog, or failure evidence is available in these reviewed sources.

Thesis: A mild opportunity prior exists only because phase-2 rationale says Voyager is a space infrastructure company with backlog growth and a DARPA-related subcontract, but this cannot be elevated because no retained within the recent evidence window evidence or citable article summaries are included in the reviewed sources.

Why now: There is no citable within the recent evidence window evidence in the reviewed sources to justify a strong 1 year+ 'why now' despite broad historical article coverage.

Caveats: Phase-2 rationale references: and: but no or summaries are provided here. Coverage debug shows 78 articles considered but 0 article IDs after recent evidence window and 0 available evidence. Ticker ambiguity exists in aliases (VOYG, VYGR), but the required output ticker is VOYG.

Thesis: The reviewed sources rationale says VSBLTY signed an LOI related to integrated AI and sovereign satellite infrastructure in the Philippines, suggesting possible adjacent upside if such positioning becomes commercially meaningful, but there is no available direct evidence, quote, or to substantiate a positive thesis.

Why now: No reviewed sources-grounded timing support is available for why this matters now over a 1 year+ horizon; the reviewed sources retains zero evidence after the cutoff and provides no citable for article.

Caveats: Reviewed evidence is limited to a membership rationale; there are no representative article summaries, or evidence after recent evidence window. The cited article id is not accompanied by a in the reviewed sources, so it cannot be used for factual claim citation. Slightly higher opportunity/risk than some peers reflects adjacency language in the reviewed sources rationale only, not strong direct evidence.

Thesis: Windward appears to have direct involvement in maritime domain awareness using integrated space-based monitoring per the reviewed sources rationale, which suggests some space-data leverage, but the reviewed sources does not establish it as a space domain awareness company and offers no retained direct evidence, so opportunity is only marginal.

Why now: There is no validated within the recent evidence window catalyst. The only support cited is phase-2 rationale referencing, and without or retained evidence.

Caveats: Reviewed evidence language distinguishes maritime domain awareness from space domain awareness. No retained article summaries or evidence are available after recent evidence window. Context-only relations must not be propagated into stronger thesis claims.

Thesis: Phase-2 rationale says Xdlinx appeared in a launch manifest with multiple 2026 missions including a quantum key distribution satellite and was listed among Indian space startups with satellite buses, but none of that is retained as in-window evidence here.

Why now: The reviewed sources includes no representative article or retained evidence within the 90-day recent evidence window, so recency and current status are uncertain for Xdlinx in this screen.

Caveats: No retained evidence after recent evidence window. Phase-2 membership support alone is not enough for a stronger score.

Thesis: The reviewed sources' membership rationale says an article identified XDLINX Space Labs as the highest-revenue company among an Indian space-tech startup sample via article: which is directionally encouraging, but no retained direct in-window evidence with is available.

Why now: No current catalyst is evidenced; coverage after recent evidence window is empty.

Caveats: Reviewed evidence mentions: but provides no. Higher-revenue claim is only from membership rationale and may not be current. No retained structured positive or negative evidence after recent evidence window.

Thesis: The reviewed sources say Zoove Space was selected for a spacetech accelerator, which is a mild positive signal for ecosystem validation and support, but the evidence is too sparse to rank it as a strong opportunity.

Why now: The reviewed sources offers no in-window evidence to confirm timing beyond the phase-2 rationale, so the current catalyst strength is limited.

Caveats: No evidence remained after the 90-day recent evidence window. Accelerator selection is a weak signal relative to financing, contracts, or operating milestones. No direct dated article is available in the reviewed sources body.

Thesis: The reviewed sources rationale says ADAspace launched a space computing cloud service platform, but no within the recent evidence window direct evidence or citable article are provided in the reviewed sources output, so that does not support a strong opportunity thesis here.

Why now: There is no usable within the recent evidence window evidence in the reviewed sources; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for ADAspace.

Caveats: Phase-2 membership rationale references article: but the reviewed sources provide no for citation. No direct positive or negative evidence survived the 90-day recent evidence window.

Thesis: AEVEX is only described as being mentioned in a space-focused SPAC and sector activity article, which is inadequate for a company-specific positive thesis.

Why now: There is no reviewed sources-grounded catalyst or timing support for a 1 year+ thesis. The reviewed sources references article id: but provides no, quote, or retained evidence row.

Caveats: Sector/SPAC mention is supporting article context and weaker than direct company-specific events or facts. No representative article summary or is present for direct citation. Low scores reflect sparse evidence, not a strong directional view.

Thesis: No direct negative evidence is retained in the reviewed sources for KVH Industries within the selected recent evidence window.

Why now: The membership rationale says KVH appeared as a listed player in a generic defense satellite communication market report tied to article: but the reviewed sources retains zero evidence after recent evidence window and provides no, so this is too weak for a directional thesis.

Caveats: Generic market-report mention is weaker than company-specific event evidence. The support article ID is cited in the reviewed sources rationale but no article or retained evidence row is provided.

Thesis: No material adverse evidence is available. The low risk score should be interpreted as insufficient evidence, not affirmative de-risking.

Why now: Why-now is weak because no within the recent evidence window evidence are available, so timing, financing status, and launch progress cannot be judged from the current reviewed sources.

Caveats: Membership rationale references, and, but no article details are available here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Potential IPO/funding relevance is mentioned only in membership rationale and cannot be elevated without direct evidence.

Thesis: No direct negative evidence is available in the reviewed sources, so no risk thesis is supportable.

Why now: The reviewed sources only describes that Intuitive Machines acquired Lanteris for about $800M via article, but provides no available evidence, no business description, and no.

Caveats: Acquisition mention without business detail is insufficient for ranking direction. No post-recent evidence window evidence are available. Referenced has no in the reviewed sources.

Thesis: No direct adverse evidence is available in the reviewed sources, and the main limitation is that Leidos appears to be a defense IT contractor rather than a core commercial space operator under these cohort rules.

Why now: No surviving evidence are available after the 90-day filter despite 300 articles considered. The rationale cites: and: but no are provided in these reviewed sources.

Caveats: Membership rationale is not direct directional proof. No retained evidence after recent evidence window. Cohort fit is ambiguous because support is infrastructure/IT modernization rather than operator economics.

Thesis: The reviewed sources does not provide direct negative evidence on LeoLabs in the available recent evidence window period, so risk scoring remains low.

Why now: No dated company-specific evidence are available after filtering, so there is no strong timing signal in these reviewed sources.

Caveats: No usable evidence after recent evidence window. Membership rationale is insufficient for a high score.

Thesis: No retained adverse evidence exists in the active recent evidence window, so only a low risk score is supportable from these reviewed sources.

Why now: The only concrete company-specific article summary says Leonardo was self-funding a 20-satellite Earth-observation constellation on February 23, 2026, but that date is older than the March 29, 2026 cutoff, so recency is insufficient for a stronger current thesis.

Caveats: The cited article is outside the 90-day recent evidence window; reviewed sources reports kept_rows 0 and dropped_rows 2. No retained positive or negative evidence exist after filtering. Article-level recap context is weaker than direct event/fact evidence.

Thesis: No retained adverse evidence is shown, so a negative thesis is likewise unsupported.

Why now: Why now is weak because 8 articles were considered but zero remained after the March 29, 2026 cutoff, leaving no current catalyst or status confirmation.

Caveats: No recent evidence window-qualified evidence. Phase-2 rationale is not enough for directional conviction.

Thesis: Insufficient retained evidence within the reviewed sources to support a material adverse thesis.

Why now: There is no available post-recent evidence window evidence for this company. The reviewed sources notes two considered articles, but zero article IDs after recent evidence window and zero evidence retained, so recency-sensitive judgment is not possible.

Caveats: The reviewed sources say support used article IDs existed earlier, but no retained evidence are available after the 90-day recent evidence window cutoff of March 29, 2026. Absence of evidence is not positive or negative proof.

Thesis: There is no direct adverse evidence in the reviewed sources; the main risk is that evidence is context-only and insufficient to assess business traction or downside.

Why now: No dated or citable event evidence is available. The reviewed sources indicates provisional single-article context tied to article id: but no or summary is provided and no evidence survived recent evidence window.

Caveats: Support level is explicitly provisional_single_article_context, which is weaker than company-specific event or fact evidence. No current evidence is provided for article: preventing direct citation. Scores remain minimal due to lack of evidence, not a strong negative view.

Thesis: No material adverse evidence is available in the reviewed sources.

Why now: There is no retained post-recent evidence window evidence row in these reviewed sources despite membership rationale referencing NASA-related wins, so timing support is insufficient.

Caveats: Membership rationale is not enough for a strong thesis without cited retained evidence. Coverage after recent evidence window is effectively zero in these reviewed sources.

Thesis: There is no direct adverse evidence in the reviewed sources within the recent evidence window; risk is scored low because the reviewed sources are evidence-empty rather than because the business is de-risked.

Why now: No within the recent evidence window company-specific catalyst or business-state change is available. Coverage debug shows 0 article IDs after recent evidence window and 0 evidence after recent evidence window, with cutoff date March 29, 2026.

Caveats: Reviewed evidence references only a profile-like article via membership rationale, not available direct evidence: but no is provided in these reviewed sources. No current source-cited evidence was found in the reviewed sources.

Thesis: There is no material adverse evidence available after recent evidence filtering; the main risk is that the company's actual role and relevance cannot be established from reviewed sources evidence.

Why now: No direct catalyst or citable business-state evidence is available. The reviewed sources references article ids: and: but provides no and no retained evidence.

Caveats: The reviewed sources explicitly says the evidence is mostly thematic/stock-basket context rather than direct business description. No or quotes are provided for direct citation.

Thesis: No material adverse thesis is supportable from the retained evidence in these reviewed sources. The low risk score reflects lack of evidence, not business quality.

Why now: Why now is weak because the reviewed sources' evidence recent evidence review shows zero kept rows after the 90-day cutoff ending March 29, 2026 and coverage data shows articles after recent evidence window of 0, so recency is not established from retained evidence.

Caveats: Phase-2 membership rationale cites but no or retained evidence row is provided in these reviewed sources, so it cannot be used for factual claims. Coverage after recent evidence window is effectively empty: evidence recent evidence review cutoff_date March 29, 2026 with kept_rows 0. Scores reflect insufficient evidence, not a fundamental bearish or bullish view.

Thesis: No material adverse thesis is supportable from the retained evidence.

Why now: Why now is weak because no evidence survived the 90-day recent evidence window in the available reviewed sources; evidence recent evidence review kept_rows is 0 and coverage data articles after recent evidence window is 0.

Caveats: Phase-2 rationale is not enough for a factual claim without and retained evidence detail. No within the recent evidence window direct evidence is available. Low scores reflect absence of usable evidence.

Thesis: No retained 90-day direct negative evidence is available to support a risk thesis.

Why now: The reviewed sources show zero retained article IDs and zero evidence after recent evidence filtering, so there is no recent company-specific evidence base for a 1 year+ directional call.

Caveats: Historical membership support references article IDs, but no post-recent evidence window evidence are served here. Low scores reflect insufficient evidence, not an evaluated business conclusion.

Thesis: No material adverse evidence is available within the reviewed sources' recent evidence window.

Why now: There is no available within the recent evidence window evidence row after the March 29, 2026 cutoff; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window for Marlan Space.

Caveats: Phase-2 membership rationale references article: but the reviewed sources provide no for citation. Partnership context alone should not be treated as propagated operating evidence under the evidence standard.

Thesis: No material negative evidence is available; the main risk is lack of current reviewed sources evidence and classification as a supplier rather than a core space operator.

Why now: There is no surviving 90-day evidence to establish a current catalyst. The rationale references and: without in these reviewed sources.

Caveats: Supplier exposure alone is not enough for a strong positive thesis without direct, timely event evidence. No retained evidence after recent evidence window.

Thesis: No adverse evidence is present. Risk stays low because there is no material negative event in the reviewed sources.

Why now: Why now is weak because there are no representative articles or available evidence after recent evidence window, and the only support is the membership rationale referencing: without article summary details in the ranking fields.

Caveats: No representative article content is included for direct citation beyond membership rationale reference. No direct positive or negative evidence are available after recent evidence window. Scoring is constrained by sparse surfaced evidence.

Thesis: There is also insufficient direct adverse evidence; the main risk is simply that the reviewed sources' support is generic and not company-event-specific, preventing a meaningful thesis ranking.

Why now: No 'why now' is evidenced. The reviewed sources show zero post-recent evidence window available evidence despite a large article universe.

Caveats: Phase-2 rationale references: but no or summary is provided. Generic market-report mention is weaker than direct company event/fact evidence. Coverage debug shows zero evidence after recent evidence window.

Thesis: No retained direct negative evidence is provided, so the reviewed sources does not support a material adverse thesis either.

Why now: Why now is weak because despite 72 articles considered, zero article IDs and zero evidence were retained after the March 29, 2026 cutoff, preventing any current sequencing or catalyst assessment.

Caveats: No admissible post-recent evidence window evidence. Membership review rationale is contextual only and not a directional scoring basis by itself.